Skip to main content

Table 2 Change in medical treatment from 6 months before to 6 months after coronary angiography in diabetes patients without coronary artery disease and with > 6 months of follow-up (n = 5661)

From: Ten-year cardiovascular risk in diabetes patients without obstructive coronary artery disease: a retrospective Western Denmark cohort study

 

Beforea

Afterb

New usersc

Former usersd

Net changee (±)

Aspirin

55.1%

53.9%

11.9%

13.0%

− 1.1%

Statins

66.6%

70.0%

9.4%

6.0%

+ 3.4%

Adenosine diphosphate-inhibitors

3.3%

4.6%

2.5%

1.2%

+ 1.3%

Vitamin-K antagonist

13.0%

19.3%

7.5%

1.2%

+ 6.3%

Direct oral anti-coagulants

2.3%

3.7%

1.7%

0.4%

+ 1.3%

Beta-blockers

46.5%

52.6%

13.0%

6.9%

+ 6.1%

Angiotensin converting enzyme-inhibitors

41.6%

43.5%

7.8%

5.9%

+ 1.9%

Angiotensin-II receptor blockers

28.4%

29.2%

4.2%

3.4%

+ 0.8%

Thiazide

19.4%

18.1%

4.5%

5.8%

− 1.3%

Calcium-blockers

32.0%

33.4%

7.7%

6.3%

+ 1.4%

Insulin

27.0%

29.9%

3.8%

0.9%

+ 2.9%

Non-insulin diabetes medication

61.6%

62.2%

4.6%

4.0%

+ 0.6%

  1. aBefore: redeemed ≥ 1 prescription within 6 months before angiography
  2. bAfter: redeemed ≥ 1 prescription within 6 months after angiography
  3. cNew user: redeemed ≥ 1 prescription within 6 months after angiography, but not 6 months before
  4. dFormer user: redeemed ≥ 1 prescription within 6 months before angiography, but not 6 months after
  5. eNet change: overall change in prescriptions from before to after angiography